Navigation Links
ADVISE Study Results Demonstrate the Instant Wave-Free Ratio™, a Vasodilator-Free Measure of Stenosis Severity, is Comparable to FFR
Date:11/14/2011

, an international multi-center study, assessed 157 stenoses in 131 patients to validate the iFR technology. Wave intensity analysis identified a wave-free period during which intracoronary resistance at rest is similar in variability and magnitude (CV:0.08+0.06 and 284+147mmHg.s/m) to that during FFR (CV:0.08+0.06 and 302+315mmHg.s/m, p=NS for both). The resting distal to proximal pressure ratio during this period, the iFR, correlated closely with FFR (r=0.9, p<0.001) with excellent diagnostic efficiency (receiver operating characteristic area under curve of 93%, at FFR<0.8), specificity, sensitivity, negative and positive predictive values of 91%, 85%, 85% and 91%, respectively. Overall diagnostic accuracy was 88%.

"The instant wave-Free Ratio (iFR) is calculated during a period in the cardiac cycle when intra-coronary resistance is naturally constant and minimized, similar to what is achieved during hyperemia with vasodilators such as adenosine over the entire cardiac cycle. We call this the 'wave-free period,' as forward- and backward-traveling wave activity has ceased," said Dr. Davies.

"In an environment where decision-making in the cath lab is increasingly questioned, Volcano is committed to delivering tools that give physicians what we call the 'moment of proof': a quantifiable measure of lesion severity that is more precise than angiography and justifies the use of a stent based on each patient's individual physiology," said Joe Burnett, EVP and General Manager of Functional Management for Volcano.

"The FAME study investigators did a tremendous job building the evidence required to move the FFR guidelines and drive physician adoption worldwide and we believe we still have plenty of opportunity ahead to improve the technology and to access more patients," said Scott Huennekens, President and CEO of Volcano. "Volcano and our partners at Imperial College London share a goal of driving the next wave of iFR
'/>"/>

SOURCE Volcano Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. ECRI Institute Advises Hospitals on How to Avoid the Pitfalls of Medical Device Connectivity
2. Trust Your Derm: The JUVA Skin & Laser Center Advises Patients To Seek Board Certified Dermatologists and AAAHC Accredited Facilities For Safe Cosmetic Procedures
3. Equipment Leasing Offers Attractive Options for Medical Practices, but Be Aware of Risks, LeClairRyan Attorney Advises
4. Carl Marks Advises Scovill Fasteners in Sale of Company
5. BB&T Advises Dr. Comfort on Its Sale to DJO Global in Transaction Valued at $254.6 Million
6. Xenogenics Corporation Retains the Emmes Group to Advise on Fund Raising Efforts
7. E. J. McKay Advises BMP Sunstone on Its USD520.6 million Sale to Sanofi- aventis
8. As Drug Prices Rise, Seniors are Advised to Review Their Medicare Prescription Coverage
9. Ecovisors to Advise Duane Reade Shoppers
10. FDA Warning: Consumers Advised Not to Use Arrow Brand Medicated Oil & - Embrocation or Aceite Medicinal La Flecha
11. Glass Lewis Advises Taro Shareholders to Hold Taros Board Accountable for Its Failures
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... Sept. 2, 2015 China Biologic Products, ... a leading fully integrated plasma-based biopharmaceutical company in ... the Company,s subsidiary Guizhou Taibang Biological Products Co., ... agreement (the "Agreement") with Xinjiang Deyuan Bioengineering Co., ... Agreement allows Guizhou Taibang to source no less ...
(Date:9/2/2015)... NEW YORK , Sept. 2, 2015 ... developing novel therapies for the treatment of chronic pain, ... investor meetings at both the FBR Second Annual Healthcare ... are as follows: FBR Second Annual Healthcare ... Seasons, Boston No presentation, ...
(Date:9/2/2015)... , Sept. 2, 2015  Kastle Therapeutics ... and commercializing pharmaceuticals for diseases with high unmet ... 3 executives to key commercial operating positions. ... Vice President, Commercial; Sean was previously Global Marketing ... been appointed as Director, Commercial Strategy and Analytics; ...
Breaking Medicine Technology:China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 2China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 3China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 4China Biologic Enters into Strategic Collaboration Agreement to Source Raw Materials 5Relmada Therapeutics to Participate in Two Upcoming Investor Conferences 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 2Kastle Therapeutics Announces Key Additions to Commercial Leadership 3
... With a Further $4m R&D Investment -- CRAIGAVON, Northern Ireland, October 7, 2010 ... ... --> ... s = ,; var first_result; // Results are keyed by longUrl, so we need to grab the ...
... Novartis Pharmaceuticals Corporation today announced the availability ... mg daily, a first-line oral treatment for relapsing ... the US Food and Drug Administration (FDA) on ... MS and healthcare professionals seeking information about Gilenya, ...
Cached Medicine Technology:Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 2Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 3Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 4Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 5Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 6Almac Continues Biocatalysis Business Growth With a Further $4m R&D Investment 7Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 2Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 3Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 4Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 5Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 6Novartis Committed to Supporting Patients and Healthcare Professionals with Education Programs and Support Services that Enhance Access to Gilenya 7
(Date:9/2/2015)... , ... September 02, 2015 , ... ... imaging, content, records and case management solutions and services to both government and ... Image Re-sizing and Image Clean-up utility for IBM’s Datacap document capture platform. ...
(Date:9/2/2015)... ... September 02, 2015 , ... “ G-Hold ” was ... and coolest technology products available to consumers. Amanda Forstrom, a technology expert and special ... designed for people to comfortably hold a tablet while reducing the likelihood of it ...
(Date:9/2/2015)... ... , ... Pentec Health, Inc., a national leader in outsourced pharmacy services, has ... year. Less than 5 % of this year’s 5000 honorees share the “six-time” recognition; ... 3-year revenue growth rate of 65% sustained its most recent achievement. As an Inc. ...
(Date:9/2/2015)... ... ... Mobile working is increasingly more important, as business professionals are looking to ... are being launched, and mobile device usage as a whole is something people around ... personal lives. What's more people are expecting mobile versions of their favorite software. , ...
(Date:9/1/2015)... ... September 01, 2015 , ... For many men, the first thing they notice when they ... forced to wear a looser fitting shirt with a collar that doesn’t close against the ... between their collar and skin all day because it’s uncomfortable. Now men in suits ...
Breaking Medicine News(10 mins):Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 2Health News:EDAC Systems, Inc. announces a new version of its Image Enhancement and Image Re-Sizing utility EDAC’s PurePAGE® 3Health News:Comfortably Hold a Tablet with G-Hold Hands Free Tablet Holder 2Health News:Pentec Health Once Again Named One of the Fastest-Growing Private Companies in America 2Health News:New Mobility Experience From Winscribe 2Health News:New Mobility Experience From Winscribe 3Health News:Getting Rid of Double Chins: New FDA Approved Kybella Treatment Proving Very Popular Among Professional Men at Crutchfield Dermatology 2
... of hope for visually- impaired patients.Retinal cell transplants can ... possibilities for them. Researchers at the University of Texas, ... a predisposition to blindness.// Experiments showed that the rats ... animals with normal vision. ,This is an ...
... Coffee is a very good stimulant in day to day ... memory performance that happens as the day progresses. During the ... adults compared to late afternoon.// For researchers at the University ... memory performance throughout the day. ,They had about ...
... that if women drink too much coffee during pregnancy can ... fits.//Studies have found that caffeine may be linked to the ... have been briefly starved of oxygen. ,A research team ... cells from the hippocampus, a part of the brain that ...
... Andhra Pradesh chief minister Chandrababu Naidu has set into ... in the port town of Vishakhapatnam. By providing world-class ... to attract global pharmaceutical companies to the city for ... 2005. The ‘Pharma City’ will be developed by private ...
... the disease gradually ended around the world. But stockpiles ... US, Russia and possibly other nations.// Recent fears of ... used to introduce the potentially deadly disease into the ... a potential outbreak. If introduced into America or Europe, ...
... a diet rich in butter and other fats, has led ... staple of the French diet. //Scientists say they have discovered ... known as polyphenols. ,Polyphenols inhibit the production ... Polyphenols in red wine decreases the amount of the peptide ...
Cached Medicine News:
... protein 4 (IGFBP-4) is a 24 kDa protein ... IGF-I and IGF-II. It is also present in ... 28 kDa. IGFBP-4 has been identified in all ... types, including fibroblasts, neuroblastoma, prostate and bone cells ...
... the adrenal gland and gonads, is the ... both of which may be subsequently converted ... activity, estimated at ~(less than or equal ... androstenedione levels often exceed testosterone in both ...
... Inhibins are heterodimeric proteins that suppress ... from the pituitary. Inhibin consists of two ... linked together. Inhibin A consists of the ... the alpha-subunit and betaB-subunit. Only the dimeric ...
... a 7.5 kDa peptide which is secreted primarily ... mitogenic and metabolic actions involved in cellular growth. ... to target cell receptors. IGF-II binds with high ... monomeric protein which also serves as the receptor ...
Medicine Products: